beta

ALPN

Alpine Immune Sciences, Inc.

Alpn

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Alpine Immune Sciences, Inc. is a development-stage pharmaceutical company, which engages in the discovering of protein-based immunotherapies therapies targeting the immune synapse to treat cancer, autoimmune, and inflammatory disorders. It offers Immunotherapy, Immune Synapse, vIgD Platform Technology, and TIP Program. The company was founded in 2015 and is headquartered in Seattle, WA.

Market Cap: 71 Million

Primary Exchange: NASDAQ

Website: http://www.alpineimmunesciences.com

Shares Outstanding: 18.6 Million

Float: 7.62 Million

Dividend: (%)

Beta: 0.0242121352876872

Sector: Health Technology

Industry: Biotechnology

Ethical Flags

Animal testing

Longest drawdown: 1089 trading days

From: 2015-08-21 To: 2019-12-10

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
2017-07-25 4.0 1.0 4.0
Data provided by IEX Cloud